SCROLL DOWN

In 2019, an estimated 10 million people fell ill with tuberculosis (TB) worldwide and 1.4 millions died from TB.1

Innovative Research & Development

Otsuka searches for innovative solutions to address gaps in TB treatment.

Responsible Access to Medicines

Otsuka’s working on widening access to a multidrug-resistant TB (MDR-TB) medicine while ensuring antimicrobial stewardship.

Collaborations

Collaboration are essential in the fight against TB.

Curbing Drug Resistance

Otsuka’s antimicrobial resistance task force works to curb resistance to antibiotics used in MDR-TB treatment.

References

1. World Health Organization. Global Tuberculosis Report 2020. World Health Organization, Geneva, 2020.

Information current as of 30-03-2021
Reference ONP-COP-2000001

Discover Otsuka